Less Ads, More Data, More Tools Register for FREE

Pin to quick picksDfs Furniture Plc Regulatory News (DFS)

Share Price Information for Dfs Furniture Plc (DFS)

Share Price is delayed by 15 minutes
Get Live Data
121.50    0.50 (0.41%)
Bid:
121.50
Ask:
123.50
Spread: 2.00 (1.646%)
Market Cap: £281.29m
DFS Live PriceLast checked at - London Stock Exchange

Intraday Dfs Furniture Plc Share Chart

Trading Statement

17 Jan 2025 07:00

RNS Number : 6623T
DFS Furniture PLC
17 January 2025
 

17 January 2025

 

Immediate release

 

DFS Furniture plc ("DFS" and the "Group")

 

Trading Update

 

Improved performance driven by market share gains, lower operating costs and gross margin improvement

 

DFS Furniture plc, the market leading retailer of living room and upholstered furniture in the United Kingdom, today announces a trading update for the twenty six week financial reporting period to 29 December 2024, together with an update on recent trading.

 

Summary:

H1 Group PBT(A)1 expected to be c£16-17m, up c+£7-8m year on year

Group order intake up +10.1% YoY2 notwithstanding a weak market backdrop, supported by successful implementation of growth initiatives and higher than expected market share gains for both brands, with Sofology's improved order intake growth trajectory continuing +19.1% YoY2

Gross delivered sales expected to be up +1.4% YoY, with order bank closing higher YoY, driven by continued Red Sea shipping delays and order intake strengthening through the period

● Profit increase driven by the higher sales, operating cost savings and gross margin improvement more than offsetting current inflationary increases

● Net bank debt at the end of the period down to £117m with leverage3 improving to 1.7x compared to 2.5x at previous financial year end

● The important Winter Sale trading period has started in line with our expectations

 

Outlook:

● The Group continues to expect full year growth in profits and cash flow with FY25 PBT expected to be in-line with current consensus

● Profit delivery now expected to be weighted to the first half driven by:

○ A cautious view on market demand in H2 based on UK economic performance post budget

○ Gains from competitor disruption in H1 expected to partially reverse in H2

○ An increase in operational costs in H2 due to the rises in national insurance contributions, the national living wage and higher than anticipated interest rates alongside our investment to drive future growth

 

The Group will announce its interim results for the period ending 29 December 2024 on 13 March 2025.

 

Comment from Tim Stacey, Group Chief Executive

"While the market remains relatively subdued, we are continuing to deliver on our self help initiatives having strengthened our position as the clear market leader, improved our gross margin and reduced our operating costs, all of which have helped us to deliver year on year profit growth.

 

We remain focused on executing our plan, and are cautiously optimistic despite the increased inflationary pressures and less positive market outlook for 2025. Looking forward, we are confident that the Group is well positioned to drive attractive returns for shareholders as the market recovers and we remain focused on delivering our 8% PBT medium-term target."

 

1 PBT(A): Underlying profit before tax and brand amortisation. Reported PBT (stated after deducting non underlying charges and brand amortisation) is expected to be in the range of £15-16m

2 Order intake growth measured using the most comparable 25 weeks of each trading period (FY25 H1: 25 weeks ending 22 Dec, FY24 H1: 25 weeks ending 24 Dec) to avoid the distorting impact caused by a different number of winter sale trading days in each trading period. All other YoY growth figures are calculated using the full 26 weeks in the current and prior year periods

3 Banking covenant IAS17 definition

4 Company compiled market consensus PBT(A) of £22.7m

 

 

Enquiries:

 

DFS (enquiries via Teneo)

Tim Stacey (Group CEO)

Marie Wall (Interim CFO)

Phil Hutchinson (Investor Relations)

investor.relations@dfs.co.uk

 

Teneo

James Macey-White

Victoria Boxall

Ayo Sangobowale

+44 (0)20 7353 4200

85fs.dfs@teneo.com

 

About DFS Furniture plc

 

The Group is the clear market-leading retailer of living room furniture in the United Kingdom. Our Group purpose is to bring great design and comfort into every home, in an affordable, responsible and sustainable manner. We operate an integrated physical and digital retail network of living room furniture showrooms and web sites in the United Kingdom and Republic of Ireland, trading through our leading brands, DFS and Sofology. We attract customers through our targeted and national marketing activities and our reputation for high quality products and service, breadth of product offer and favourable consumer financing options. We fulfil orders for our exclusive product ranges through our own UK finished goods factories, and through manufacturing partners located in the UK, Europe and Far East, and delivered with care through our expert final-mile delivery service "The Sofa Delivery Company Limited".

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
TSTFLFSRLLIRLIE
Date   Source Headline
20th May 20264:31 pmRNSHolding(s) in Company
6th May 20267:00 amRNSDirectorate change
30th Apr 20267:00 amRNSPurchase of shares by Employee Benefit Trust
1st Apr 20263:06 pmRNSEBT Update
19th Mar 20267:00 amRNSInterim Results
20th Jan 20267:00 amRNSTrading Statement
31st Dec 20257:00 amRNSHolding(s) in Company
31st Dec 20257:00 amRNSHolding(s) in Company
31st Dec 20257:00 amRNSHolding(s) in Company
31st Dec 20257:00 amRNSHolding(s) in Company
31st Dec 20257:00 amRNSHolding(s) in Company
31st Dec 20257:00 amRNSHolding(s) in Company
30th Dec 20257:00 amRNSTotal Voting Rights
8th Dec 20251:40 pmRNSTotal Voting Rights
17th Nov 20257:00 amRNSDirector/PDMR Shareholding
14th Nov 20254:17 pmRNSDirectorate change
14th Nov 20253:47 pmRNSResult of AGM
14th Nov 20257:00 amRNSAGM Trading Statement
13th Nov 20257:00 amRNSDirector/PDMR Shareholding
23rd Oct 20251:19 pmRNSDirector/PDMR Shareholding
21st Oct 20257:00 amRNSDirector/PDMR Shareholding
20th Oct 202510:35 amRNSDirector/PDMR Shareholding
17th Oct 20257:00 amRNSDirector/PDMR Shareholding
14th Oct 20257:00 amRNSAnnual Financial Report
25th Sep 20257:00 amRNSFY25 Preliminary Results
12th Aug 20258:00 amRNSDirector Declaration
17th Jul 20257:00 amRNSTrading Statement
13th May 202511:59 amRNSHolding(s) in Company
10th Apr 202512:46 pmRNSInvestor Presentation via Investor Meet Company
9th Apr 202511:29 amRNSDirectorate Change
4th Apr 202510:37 amRNSHolding(s) in Company
13th Mar 20257:00 amRNSInterim Results
24th Feb 20257:00 amRNSDirectorate Change
12th Feb 20251:15 pmRNSChange of Adviser
7th Feb 20253:14 pmRNSHolding(s) in Company
5th Feb 20259:28 amRNSHolding(s) in Company
29th Jan 20257:00 amRNSDirectorate Change
17th Jan 20257:00 amRNSTrading Statement
8th Jan 202512:05 pmRNSHolding(s) in Company
7th Jan 202512:34 pmRNSHolding(s) in Company
6th Jan 20252:47 pmRNSHolding(s) in Company
3rd Jan 20252:17 pmRNSHolding(s) in Company
13th Dec 20247:00 amRNSDirector/PDMR Shareholding
27th Nov 20247:00 amRNSHolding(s) in Company
27th Nov 20247:00 amRNSValidation of SBTi Targets
25th Nov 202411:52 amRNSHolding(s) in Company
25th Nov 202410:57 amRNSHolding(s) in Company
22nd Nov 20243:31 pmRNSResult of AGM
22nd Nov 20247:00 amRNSTrading Update and Directorate Change
19th Nov 20249:51 amRNSHolding(s) in Company

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.